Ingrid Hoos

General Counsel bij ETON PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Profiel

Ingrid Hoos is currently working as the Senior Vice President of Regulatory Affairs at Eton Pharmaceuticals, Inc. She previously held the position of VP of Regulatory Affairs & Regulatory Compliance at Horizon Pharma, Inc. and worked in Regulatory Affairs at Baxter Healthcare, Inc. In terms of education, Ms. Hoos completed her undergraduate degree at Northeastern Illinois University.

Actieve functies van Ingrid Hoos

Bedrijven	Functie	Begin
ETON PHARMACEUTICALS, INC.	General Counsel	-

Alle actieve functies van Ingrid Hoos

Eerdere bekende functies van Ingrid Hoos

Bedrijven	Functie	Einde
Baxter Healthcare, Inc.	Corporate Officer/Principal	-
Horizon Pharma, Inc. Horizon Pharma, Inc. Pharmaceuticals: MajorHealth Technology Horizon Pharma, Inc. discovers and develops medicines for the treatment of chronic inflammatory diseases. It is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company products include DUEXIS (ibuprofen and famotidine) Tablets, is a proprietary, single-tablet combination of the non-steroidal anti-inflammatory drug ibuprofen and the histamine H2-receptor antagonist famotidine; RAYOS (prednisone) delayed-release tablets, known as LODOTRA outside the U.S., is a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe, active RA in adults, particularly when accompanied by morning stiffness. Horizon Pharma was founded on March 23, 2010 and is headquartered in Deerfield, IL.	General Counsel	-

Ervaring van Ingrid Hoos in detail bekijken

Opleiding van Ingrid Hoos

Northeastern Illinois University

Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Ingrid Hoos in detail bekijken

Connecties

Eerstegraads connecties

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven	1
ETON PHARMACEUTICALS, INC.	Health Technology

Bedrijven in privébezit	2
Horizon Pharma, Inc. Horizon Pharma, Inc. Pharmaceuticals: MajorHealth Technology Horizon Pharma, Inc. discovers and develops medicines for the treatment of chronic inflammatory diseases. It is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company products include DUEXIS (ibuprofen and famotidine) Tablets, is a proprietary, single-tablet combination of the non-steroidal anti-inflammatory drug ibuprofen and the histamine H2-receptor antagonist famotidine; RAYOS (prednisone) delayed-release tablets, known as LODOTRA outside the U.S., is a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe, active RA in adults, particularly when accompanied by morning stiffness. Horizon Pharma was founded on March 23, 2010 and is headquartered in Deerfield, IL.	Health Technology
Baxter Healthcare, Inc.